Logo FIGO 2018 | World Congress of Gynecology and Obstetrics
#FIGO2018 #EveryWomanMatters

COMPANYTHEME
Company: NESTLE
Room: 201 (A+B) - Raymond Keller
Symposia Title: Preventive Aspects During Pregnancy and Lactation: Is There a Role for Nutritional Interventions?
Speakers: Nutritional Interventions to Reduce the Risk of Gestational Diabetes Mellitus
Dr. Enrique Reyes | Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, México
Lactational Mastitis: Is There a Role for Probiotics?
Dr. Jose Antonio Hurtado | Neonatal Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Chair person: Prof. Chittaranjan N. Purandare - President FIGO, Dean Indian College Of Obstetrics and Gynaecology

Company: Bayer – YAZ FLEX
Room: 203 (A+B) - Howard Taylor
Yaz® Flex: Flexible Regimen a new concept of of contraception
Chairman Doctor Cesar Fernandes

13:00 - 13:05 - Welcome and Agenda - Dr. Cesar Fernandes
13:05 - 13:25 - The powerful impact of flexible regimen on women's lives - Dr. Johannes Bitzer
13:25 - 13:45 - Yaz® Flex: A revolution contraception - Dr. Rogério Bonassi
13:45 - 13:55 - Q&A - All
13:55 - 14:00 - Wrap up and closure - Dr. Cesar Fernandes

Company: DEKA
Room: 201C  - Alfonso Álvarez Bravo
TREATMENT OF VAGINAL ATROPHY WITH CO2 FRACTIONAL:CLINICAL RESULTS
Stefano Salvatore
Dept of Obstetrics and Gynecology, San Raffaele Hospital, Milan - Italy

COMPANYTHEME

Company: Ferring
Room: 201 (A+B) - Raymond Keller
Title: Every woman matters: Challenging PPH prevention in 2018
Chairs: Gian Carlo Di Renzo (Italy), Eduardo Fonseca (Brazil)

13:15 - Introduction - Eduardo Fonseca (Brazil)
13:15–13:35 - PPH – The need for further research - Sabaratnam / Arulkumaran (UK)
13:35–13:55 - CHAMPION – The largest PPH prevention study - Zahida Qureshi (Kenya)
13:55–14:15 - IMox – Comparative clinical trial in the UK setting - Tim Draycott (UK)
14:15 - Close - Gian Carlo Di Renzo (Italy)

Company: Tonederm
Room: 203 (A+B) - Howard Taylor
Invasive and non-invasive treatment: the importance of radiofrequency with transcutaneous temperature control in the treatment of the menopausal urogenital syndrome and the vaginal laxity syndrome.
Ministrantes:
Dra. Isabel Berardinelli
Dra. Magda Furlanetto
Cristiano Paganin
Company: Natural Cycles Fishawack
Room: 205  - Roberto Caldeyro-Barcia

Exploring the Role of Digital Fertility Awareness Based Methods of Contraception
13:15-13:35 - ‘The Unmet Need for More Contraceptive Choice’ Prof Johannes Bitzer,
University of Basel, Switzerland.
13:35-13:55 - ‘Utilising algorithms to optimise clinical care’ Prof Juan Acuna, Florida
International University, USA.
13:55-14:15 - ‘The evidence base for evaluation of Digital Fertility Awareness Based
Methods of Contraception’ Prof Kristina Gemzell-Danielsson, Karolinska Institutet,
Sweden.
14:15-14:30 - Q&A
Company: Roche
Room:
201C  - Alfonso Álvarez Bravo
Title: “Personalized reproductive medicine: the role of Anti-Müllerian Hormone”
Moderator: Dr Alvaro Petracco (Clinica Fertilitat, Porto Alegre, Brazil)
Program:
The value of AMH from infertility assessment to treatment individualization 
Dr Gustavo Maciel (Universidade de Sao Paulo (USP), Brazil)
New horizons in ovarian stimulation: AMH-based dosing of follitropin delta
Dr Ernesto Bosch (IVI-RMA Valencia, Spain)

COMPANYTHEME
Company: ELMECO
Room: 201 (A+B) - Raymond Keller
Hormonal Implants in gynecology and endocrinology.
Elsimar Metzker Coutinho
Company: Bayer – MIRENA
Room: 203 (A+B) - Howard Taylor
Challenging the status quo: how to increase LARCs utilization rates
Chairman Dr. Agnaldo Silva

13:00 - 13:05 - Welcome and Agenda - Dr. Agnaldo Silva
13:05 - 13:25 - EU guidelines and experience - Dr. Kristina Gemzell
13:25 - 13:45 - US guidelines and experience - Dr. Anita Nelson
13:45 - 13:55 - Q&A - All
13:55 - 14:00 - Wrap up and closure - Dr. Agnaldo Silva

Company: MSD
Room: 205  - Roberto Caldeyro-Barcia
HPV vaccination: where we are and where we want to go?

01:00 - 01:10 HPV vaccination: LATAM current status .
01:10 - 01:30 Opportunities in HPV disease prevention: gender-neutral vaccination and mid-adult women. Luisa Villa, PhD
01:30 - 01:50 Real-World Effectiveness of 4vHPV Vaccination Programs. Edson Moreira, MD, PhD
01:50 - 02:00 Q&A
Company: Vifor pharma
Room: 207 - José Pinotti
Blood loss and the iron need in women: can we do more?
Introduction: Ilza Monteiro (co-chair)
Iron deficiency: a missed opportunity
Rodolfo Cançado (co-chair)
Peri-partum bleeding – an update on treatment approaches to optimize outcomes
Irene Hösli
LATAM consensus – a step by step guide on improving women’s health
Pablo Carpintero
Q&A

Company: Kedrion
Room: 210 - Giuseppe Tesauro
50 Years of Anti D prophylaxis: Accomplishments and Challenges
Chairpersons: G C Di Renzo, G H Visser

13:00 - 13:10 G C Di Renzo Introduction and video
13:10 - 13.30 G H Visser Global burden of Rh disease: how far are we away from eradication?
13:30 – 13:50 E Fonseca Rh disease in Brazil nowadays
13:50 – 14:10 D Farine Rh disease in Canada : first country to adopt the nationwide prevention
14:10 – 14:30 a "Women Delivery" speaker (TBA) The role of women in preventing HDFN

Company: Roche
Room: 201C - Alfonso Álvarez Bravo
How is cfDNA testing best implemented? Should we limit testing to singleton pregnancies?
Maria Del Mar GIL, MD, PhD
Hospital Universitario de Torrejón - Madrid, Spain
 How do different cfDNA tests compare? Should we expand the scope of cfDNA testing beyond common trisomies?
Gian Carlo DI RENZO, MD, PhD
University Hospital of Perugia -Perugia, Italy

COMPANYTHEME

Company: GSK
Room: 201 (A+B) - Raymond Keller
Title: Share protection through Maternal Immunization: your role is key in newborn pertussis prevention
Program (65 mins presentations & 25 mins Q&A) - speakers to be confirmed:

13:00-13:05 Introduction and welcome
13:05-13:25 Pertussis in neonates: why there is a need for Maternal Immunization?
13:25-13:45 The UK experience in Maternal Immunization implementation
13:45-14:05 Best practices on how to discuss Maternal Immunization with pregnant patients
14:05-14:30 Concluding remarks and round-table discussion, with questions from the audience

Company: Bayer – CONSUMER
Room: 203 (A+B) - Howard Taylor
NATELE®: Micronutrients in pregnancy: the foundation for development and lifelong health
Chairman Dr. Eduardo Fonseca

13:00 - 13:05 - Welcome and Agenda - Dr. Eduardo Fonseca
13:05 - 13:20 - Nutricionals status of women of child bearing age in Brazil/LATAM - Dr. Eduardo Fonseca
13:20 - 13:35 - Critical role of micronutrients during pregnancy and lactation - Prof. Berthold Koletzko
13:35 - 13:50 - Micronutrients deficiency and epigenetic signatures in the placenta - Prof. Irene Cetin
13:50 - 14:00 - Q&A, Wrap up and Summary - Dr. Eduardo Fonseca

Company: SANOFI
Room: 205  - Roberto Caldeyro-Barcia
O manejo do TEV na mulher: principais guidelines e condutas internacionais
Dr. André Luiz Malavasi
VTE management in women: the main guidelines and international conducts
Dr. André Luiz Malavasi

Company: OM Pharma AS (Vifor pharma group)
Room: 207  - José Pinotti
Filling the gap between Guidelines and clinical practice in UTI management

13:15 - Welcome - Chairman: Prof. Jorge Haddad
13:20 - Disease burden and importance of proper diagnosis and identification of patients at risk for recurrent UTIs - Dr. Jakhonghir Alidjanov
13:35 - Guidelines in urological infections: overview on prophylaxis -Prof. Suzanne Geerlings
13:50 - How to achieve an improved management of UTI in clinical practice: a LATAM consensus - Prof. Jorge Haddad
14:05 - Discussion - All
14:15 - End of the symposium - All

PATROCINIO

DIAMANTE

bayer_220x220
gsk_220x220

ORO

grudenthal
logo_mds

PLATA

ems_ok
fqm_ok
nestle_ok

COBRE

NN_2c_200x100

BRONCE

perkin_elmer

ZAFIRO

besins-200x100-
smb-200x100
storz

RUBI

APOYO ESPECIAL

EXPOSITOR

Scroll Up